ACP’s New Guidance Endorses Two COVID-19 Drugs, Advises Against Two
ACP issued four practice points on the pharmacologic and biologic treatment of COVID-19 in the outpatient setting, endorsing two drugs and advising against two others.
ACP issued four practice points on the pharmacologic and biologic treatment of COVID-19 in the outpatient setting, endorsing two drugs and advising against two others.
Researchers found that smoking significantly shortens telomeres—indicators of aging and cellular repair capability—and the more cigarettes consumed, the greater the shortening effect.
Neonatal pulmonary disorders may require additional respiratory support beyond supplemental oxygen, such as nasal CPAP, HFNC, nasal BiPAP, NIPPV, nHFOV, or even NIV-NAVA.
Mount Sinai's newly developed ventilatory burden offers a potentially more effective alternative to the traditional AHI in assessing severity in sleep apnea patients.
Living in a neighborhood with better access to resources during the early stages of childhood was associated with lower asthma incidence in a new study from the NIH's Environmental influences on Child Health Outcomes program.
The FDA approved Moderna's updated COVID-19 vaccine (Spikevax) for ages 12 years and above, and issued emergency use authorization for children age 6 months through 11 years old.
Researchers urge lawmakers to increase the legal age to buy tobacco to 22 years or older, which could lead to a reduction in the number of people addicted to nicotine.
Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock who are scheduled for early revascularization, according to ESC 2023 data.
Researchers have discovered some new and surprising ways that viral RNA and influenza viruses are detected by human lung cells, which have potential implications for treating people affected by such viruses.